Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New trial aims to personalize cancer treatment using rapid immune profiling

NCT ID NCT07431073

Summary

This trial aims to improve cancer treatment by matching patients with advanced solid tumors to specific immunotherapies based on a detailed analysis of their individual tumor and immune system. Researchers will use a rapid testing platform called PORTRAIT on fresh blood and tumor samples to create a biological profile for each patient. The goal is to see if this personalized matching leads to better treatment outcomes than the current standard approach.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED/ METASTATIC SOLID TUMORS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.